ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.17
-0.25%
Dow Jones
39,134.76
0.77%
US Dollar vs MXN
18.3628
-0.39%
Brent Oil
85.015
0.38%
Bitcoin
65,005.90
0.06%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) Noticias

PRAX Praxis Precision Medicines Inc

40.11
2.42 (6.42%)
Fuera de horario
Última actualización: 16:30:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Praxis Precision Medicines Inc PRAX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
2.42 6.42% 40.11 16:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
34.19 33.01 41.7742 40.11 37.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/6/202415:56EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/6/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202416:09EDGAR2Form 8-K - Current report
20/5/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202407:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202407:18EDGAR2Form 8-K - Current report
12/4/202407:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/3/202408:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/3/202406:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:13EDGAR2Form 8-K - Current report
05/3/202406:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202419:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/1/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202416:23EDGAR2Form 8-K - Current report
12/1/202416:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202405:01EDGAR2Form 8-K - Current report
10/1/202416:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202415:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
10/1/202415:10EDGAR2Form 8-K - Current report
09/1/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202316:23EDGAR2Form 8-K - Current report
07/12/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202315:33EDGAR2Form 8-K - Current report
28/11/202306:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
21/11/202315:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
16/11/202307:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
07/11/202306:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:35EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
06/11/202315:24EDGAR2Form 8-K - Current report
02/11/202307:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
16/10/202306:09EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202306:56EDGAR2Form PRE 14A - Other preliminary proxy statements
02/10/202312:27EDGAR2Form 8-K - Current report
02/10/202312:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
27/9/202315:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
19/9/202309:25APSBiotech Catches Major Premarket Bid

Su Consulta Reciente

NASDAQ
PRAX
Praxis Precision Medicines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados